Warning letter
Xi'an Livingbond Nonwoven Products Corp., Ltd.: warning letter of Jun 10, 2019
FDA warning letter 574591 · Center for Drug Evaluation and Research
Key facts
| Reference number | 574591 |
|---|---|
| Company | Xi'an Livingbond Nonwoven Products Corp., Ltd. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Misbranded |
| Issue date | Jun 10, 2019 |
| Posted date | Jun 25, 2019 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.34, 211.84(d)(1), 211.100(a), 211.165(a), 211.22(a), 201.128 |
| Inspection city | Xian |
| Inspection start date | Jan 7, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: